Treace Medical Concepts TMCI
NASDAQ TMCI
$4.46 -0.10 (-2.19%)
At close: Aug 20, 2026 · 4:00 PM EDT

Treace Medical Concepts (TMCI) EBT Margin Growth (3y) (2023 - 2026)

Treace Medical Concepts (TMCI) EBT Margin Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -429.00
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 574.00
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 55.00
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 764.00
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 835.00
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 598.00
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 125.00
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 631.00
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 423.00
10 Treace Medical Concepts 290.12 Mn 244.50 Mn 35.61 Mn -595.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,123.00
Mar 31, 2026 -1,198.00
Dec 31, 2025 -299.00
Sep 30, 2025 395.00
Jun 30, 2025 1,384.00
Mar 31, 2025 8,958.00
Dec 31, 2024 1,853.00
Sep 30, 2024 88,848.00
Jun 30, 2024 109,829.00
Mar 31, 2024 41,503.00
Dec 31, 2023 -1,889.00
Sep 30, 2023 -2,443.00
Jun 30, 2023 -398.00
Mar 31, 2023 -1,791.00